Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Recruiting · NCT05687188 · Observational (researchers observe without assigning treatment) · Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute
View the official record on ClinicalTrials.gov →Interventions studied
Blood Sample CollectionData CollectionMedical Image CollectionTissue Sample Collection
What this trial is about
This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adults 18 years of age or older at time of signing informed consent
- Patients who self-report as African American, Non-Hispanic White
- Patients who present to the gastrointestinal (GI) clinic, surgery, or endoscopy at a participating Florida Pancreas Collaborative (FPC) site or the University of Mississippi Medical Center (UMMC) with a clinical suspicion or diagnosis of a pancreatic tumor.
Exclusion criteria
- Patient under 18 years of age
- Has no suspicion or diagnosis of a pancreatic cancer or tumor
- Self-reported race/ethnicity other than African American or Non-Hispanic White.
Where it is running
4 locations listed across 2 US states.
- Moffitt Cancer Center - Tampa, Florida, United States
- Moffitt Cancer Center - Tampa, Florida, United States
- University of Mississippi Medical Center - Jackson, Mississippi, United States
- University of Mississippi Medical Center - Jackson, Mississippi, United States